Motoki Watanabe

526 total citations
35 papers, 397 citations indexed

About

Motoki Watanabe is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Motoki Watanabe has authored 35 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Motoki Watanabe's work include Cancer-related Molecular Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Motoki Watanabe is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Motoki Watanabe collaborates with scholars based in Japan and United States. Motoki Watanabe's co-authors include Toshiyuki Sakai, Yoshihiro Sowa, Yosuke Iizumi, Mamiko Sukeno, Tetsuya Taguchi, Mano Horinaka, Koichi Sakaguchi, Shogen Boku, Larry Ereshefsky and Tram Tran-Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Motoki Watanabe

31 papers receiving 393 citations

Peers

Countries citing papers authored by Motoki Watanabe

Since Specialization

Citations

This map shows the geographic impact of Motoki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoki Watanabe more than expected).

Fields of papers citing papers by Motoki Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motoki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoki Watanabe. The network helps show where Motoki Watanabe may publish in the future.

Co-authorship network of co-authors of Motoki Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Motoki Watanabe. A scholar is included among the top collaborators of Motoki Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motoki Watanabe. Motoki Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trametinib Suppresses the Stimulated T Cells Through G1 Arrest and Apoptosis 2025 ·European Journal of Immunology ·Toshimasa Nakao, Takero Shindo, Hideki Takakura, (unknown), (unknown), (unknown), Yosuke Iizumi, Shogen Boku, Motoki Watanabe, Toshiyuki Sakai, Seiichi Shimizu, Masaki Yamada, Yoshihiro Sowa, Michihiro Mutoh	0
2	Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), (unknown), (unknown), Eiichi Konishi, Isao Yokota, Shogen Boku, Naruhiko Mizuta, (unknown), Koichi Sakaguchi, Tetsuya Taguchi, Motoki Watanabe, Yasuto Naoi	2
3	Induction of <i>MYCN</i>-amplified neuroblastoma differentiation through NMYC suppression using PPAR-γ antagonist 2023 ·Journal of Clinical Biochemistry and Nutrition ·(unknown), (unknown), Shingo Miyamoto, Motoki Watanabe, Takuji Tanaka, Yoshihiro Sowa, Yosuke Iizumi, Mitsuharu Masuda, Gen Fujii, Yasuko Hirai, Toshimasa Nakao, Hideki Takakura, Michihiro Mutoh	0
4	A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5 2022 ·PNAS Nexus ·Motoki Watanabe, Shogen Boku, (unknown), (unknown), Mamiko Sukeno, Mitsuharu Masuda, Katsura Mizushima, (unknown), Yosuke Iizumi, Kiichi Hirota, Yuji Naito, Michihiro Mutoh, Tomoshi Kameda, Toshiyuki Sakai	1
5	Stabilization of CDK6 by ribosomal protein uS7, a target protein of the natural product fucoxanthinol 2022 ·Communications Biology ·Yosuke Iizumi, Yoshihiro Sowa, (unknown), (unknown), Motoki Watanabe, (unknown), Tomoshi Kameda, Kenichi Akaji, Masatoshi Kitagawa, Toshiyuki Sakai	1
6	Importance of sessile serrated lesions in a patient with familial adenomatous polyposis 2021 ·Clinical Journal of Gastroenterology ·Motoki Watanabe, Hideki Ishikawa, Shingo Ishiguro, Michihiro Mutoh	0
7	Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosis 2020 ·International Journal of Oncology ·Yusuke Chihara, Yosuke Iizumi, Mano Horinaka, Motoki Watanabe, (unknown), (unknown), (unknown), Yoshihiro Sowa, Tadaaki Yamada, Koichi Takayama, Toshiyuki Sakai	5
8	Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia 2019 ·International Clinical Psychopharmacology ·Nobuhisa Kanahara, Kensuke Yoshimura, (unknown), Yasunori Oda, Motoki Watanabe, Masaomi Iyo	3
9	Combination effects of MEK inhibitors with statins on cancer cells 2018 ·Annals of Oncology ·(unknown), Motoki Watanabe, Tetsuya Taguchi, Toshiyuki Sakai	1
10	Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma 2018 ·Cancer Letters ·Nobuhisa Hagiwara, Motoki Watanabe, (unknown), Isao Yokota, (unknown), Mamiko Sukeno, (unknown), Yoshihiro Sowa, Fumiya Hongo, Kazuya Mikami, Jintetsu Soh, Akira Fujito, Hiroaki Miyashita, (unknown), Tsuneharu Miki, Osamu Ukimura, Toshiyuki Sakai	20
11	The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway 2018 ·Breast Cancer Research and Treatment ·(unknown), Yoshihiro Sowa, Mano Horinaka, Yosuke Iizumi, Motoki Watanabe, (unknown), (unknown), Tetsuya Taguchi, Toshiyuki Sakai	17
12	The pleiotropic regulation of cyclin D1 by newly identified sesaminol-binding protein ANT2 2017 ·Oncogenesis ·Motoki Watanabe, Yosuke Iizumi, Mamiko Sukeno, (unknown), Yoshihiro Sowa, Toshiyuki Sakai	31
13	Effectiveness of blonanserin for patients with drug treatment-resistant schizophrenia and dopamine supersensitivity: A retrospective analysis 2016 ·Asian Journal of Psychiatry ·(unknown), Tomihisa Niitsu, Motoki Watanabe, Tasuku Hashimoto, Nobuhisa Kanahara, Masatomo Ishikawa, Masaomi Iyo	11
14	Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer 2016 ·Cell Death and Disease ·Toshiyasu Taniguchi, Yosuke Iizumi, Motoki Watanabe, Michiaki Masuda, Masaru Morita, (unknown), (unknown), Masamichi Oishi, (unknown), Toshiyuki Sakai	43
15	Phosphorylated retinoblastoma protein is a potential predictive marker of irinotecan efficacy for colorectal cancer 2016 ·International Journal of Oncology ·Atsushi Ikai, Motoki Watanabe, Yoshihiro Sowa, Mitsuo Kishimoto, Akio Yanagisawa, Hitoshi Fujiwara, Eigo Otsuji, Toshiyuki Sakai	5
16	Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)‐reactivating agents enhance efficacy of 5‐fluorouracil on human colon cancer cells 2013 ·Cancer Science ·Motoki Watanabe, Yoshihiro Sowa, (unknown), Toshiyuki Sakai	37
17	Perillyl alcohol causes G1 arrest through p15INK4b and p21WAF1/Cip1 induction 2012 ·Oncology Reports ·Makoto Koyama, Yoshihiro Sowa, Toshiaki Hitomi, Yosuke Iizumi, Motoki Watanabe, (unknown), (unknown), Toshiyuki Sakai	25
18	Acute cholecystitis due to strangulation of a floating gallbladder by the lesser omentum 2006 ·Abdominal Imaging ·Taro Ueo, Shujiro Yazumi, (unknown), Yayoi Okada, Takashi Oono, Motoki Watanabe, (unknown), (unknown), (unknown), Takahiro Mori, Hideo Tomioka, (unknown), Shigeto Mizuno, T. Chiba, (unknown)	8
19	Early resection of primary orthotopically-growing human colon tumor in nude mouse prevents liver metastasis: further evidence for patient-like hematogenous metastatic route. 1993 ·PubMed ·Tsong‐Hong Kuo, Tetsuro Kubota, Motoki Watanabe, Toru Furukawa, Tsukasa Teramoto, Kyuya Ishibiki, Michio Kitajima, Richard M. Hoffman	25
20	The effect of immunotoxin against human glioma cells 1989 ·min - Minimally Invasive Neurosurgery ·Yoshinobu Manome, Motoki Watanabe, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact